[1] Littera R,Chessa L,Onali S,et al. Exploring the role of killer cell immunoglobulin-like receptors and their HLA class I ligands in autoimmune hepatitis. PLoS One,2016,11（1）:e0146086.
[2] Canivet CM,Anty R,Patouraux S,et al. Immunoglobulin G4-associated autoimmune hepatitis may be found in western countries. Dig Liver Dis,2016,48（3）:302-308.
[3] Czaja AJ. Transitioning from idiopathic to explainable autoimmune hepatitis. Dig Dis Sci,2015,60（10）:2881-2900.
[4] Than NN,Wiegard C,Weiler-Normann C,et al. Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on tacrolimus therapy. Scand J Gastroenterol,2016,51（3）:329-336.
[5] Manns MP,Lohse AW,Vergani D. Autoimmune hepatitis update-2015. J Hepatol,2015,62（1 Suppl）:S100-S111.
[6] 中华医学会感染病学分会,肝脏炎症及其防治专家共识专家委员会, 肝脏炎症及其防治专家共识. 中国实用内科杂志,2014,34：152-161.
[7] 刘露露,乔宽,王炳元. 老年自身免疫性肝炎患者临床检验特点分析. 实用肝脏病杂志,2017,20（1）:46-50.
[8] Zhu GQ,Shi KQ,Huang GQ,et al. A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis. Oncotarget,2015,6 （29）: 26757-26669.
[9] 艾月梅,严玉娟,邢益平. 自身免疫性肝病临床诊治研究进展. 实用肝脏病杂志,2016,19（3）:360-364.
[10] He R,Wang L,Zhu J,et al. Methane-rich saline protects against concanavalin A-induced autoimmune hepatitis in mice through anti-inflammatory and anti-oxidative pathways. Biochem Biophys Res Commun,2016,470（1）:22-28.
[11] Battagliotti C,Rispolo Klubek D,Karakachoff M,et al. An overlap syndrome involving systemic lupus erythematosus and autoimmune hepatitis in an adolescent girl. Arch Argent Pediatr,2016,114（3）:e155-e158.
[12] 任方元,李小丹. 中西医结合治疗I型自身免疫性肝炎患者临床疗效研究. 实用肝脏病杂志,2016,19（5）:549-552.
[13] Gatselis NK,Zachou K,Koukoulis GK,et al. Autoimmune hepatitis,one disease with many faces:etiopathogenetic,clinico-laboratory and histological characteristics. World J Gastroenterol,2015,21（1）:60-83.
[14] Wunsch E,Trottier J,Milkiewicz M,et al. Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis. Hepatology,2014,60（3）:931-940. |
